Pilot data indicates efficacy from anakinra against endometriosis
The interleukin-1 (IL-1) antagonist anakinra (Kineret; Swedish Orphan Biovitrum) has shown efficacy against endometriosis symptoms, according to a pilot study published in the International Journal of Women’s Health.1 Endometriosis is reported in 5% to 10% …